Here are 5 anti-obesity drug stocks besides Novo Nordisk and Eli Lilly to watch into year-end – CNBC

by

  1. Here are 5 anti-obesity drug stocks besides Novo Nordisk and Eli Lilly to watch into year-end CNBC
  2. Bond yield rally has already priced in another potential rate hike, says Parametric’s Nisha Patel CNBC Television
  3. Earnings playbook: Your guide to trading another busy week of reports, including Apple and Pfizer CNBC
  4. Interest rates are ‘hollowing out’ the underlying market structure, says 3Fourteen’s Warren Pies CNBC Television
  5. Analyzing the market sell-off: Routine S&P 500 correction or something more serious? CNBC
  6. View Full Coverage on Google News

Read original article here

Leave a Comment